Evaluation and care of patients with diabetic retinopathy

Lee M. Jampol, Adam R. Glassman*, Jennifer Sun

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

155 Scopus citations

Abstract

Vascular complications of diabetes mellitus, including the evolution of the retinal damage known as diabetic retinopathy, have been recognized for centuries. Over the past decade, advances in technology such as retinal imaging and the development of new therapies have dramatically improved the evaluation, treatment, and visual outcomes of patients with diabetic retinopathy. Nonetheless, diabetic macular edema and proliferative diabetic retinopathy remain the leading causes of both moderate and severe vision loss in most developed countries. This article reviews the worldwide effect of diabetic retinopathy and recent changes in the evaluation and treatment of affected patients.

Original languageEnglish (US)
Pages (from-to)1629-1637
Number of pages9
JournalNew England Journal of Medicine
Volume382
Issue number17
DOIs
StatePublished - Apr 23 2020

Funding

Dr. Jampol reports receiving consulting fees from Sanofi Pharmaceuticals; Mr. Glassman, receiving grant support, paid to his institution, from Genentech, Regeneron, and Allergan; and Dr. Sun, receiving grant support and provision of equipment from Optovue, provision of equipment from Boston Micro-machines and Adaptive Sensory Technologies, grant support and travel support from Kalvista, Novo Nordisk, and Boehringer Ingelheim, consulting fees and travel support from Merck and Novartis, and grant support, medical writing, and travel support from Roche. No other potential conflict of interest relevant to this article was reported.

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Evaluation and care of patients with diabetic retinopathy'. Together they form a unique fingerprint.

Cite this